| Product Code: ETC067009 | Publication Date: Aug 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Non-Oncology Precision Medicine Market was estimated at USD 1233 Million in 2025 and is projected to reach USD 1751 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This impressive growth trajectory is underpinned by the rising incidence of non-oncological diseases such as cardiovascular and neurological disorders, which are increasingly demanding tailored medical solutions. Furthermore, advancements in genetic testing technologies and supportive government initiatives are enhancing accessibility to personalized treatment options across the country.
This graph highlights how the Vietnam Non-Oncology Precision Medicine Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.2% | Growing urbanization and commercial development |
| 2022 | 3.1% | Rising electricity demand across industries |
| 2023 | 8.2% | Increasing adoption of advanced technologies |
| 2024 | 5.1% | Expansion of transportation and logistics networks |
| 2025 | 6.4% | Increasing industrial automation investments |
| 2026 | 8.3% | Government infrastructure modernization initiatives |
| 2027 | 7.8% | Growing urbanization and commercial development |
| 2028 | 6.7% | Increasing adoption of advanced technologies |
| 2029 | 6.3% | Increasing industrial automation investments |
| 2030 | 6.1% | Increasing industrial infrastructure investments |
| 2031 | 5.5% | Increasing smart city development projects |
| 2032 | 5.6% | Government infrastructure modernization initiatives |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Vietnam Non-Oncology Precision Medicine market is experiencing a transformative phase, propelled by increased awareness and technological advancements. As healthcare providers pivot towards more personalized medicine approaches, the sector is witnessing a surge in demand for innovative diagnostic and therapeutic solutions tailored to individual patient profiles.
Looking ahead, the market's future appears promising, driven by the government's commitment to enhancing healthcare infrastructure and the burgeoning biotechnology landscape. This momentum is expected to accelerate the integration of precision medicine into mainstream healthcare, addressing critical health challenges effectively.
Despite its rapid development, the Vietnam Non-Oncology Precision Medicine market grapples with certain constraints. One major hurdle lies in the necessity for comprehensive genetic profiling, which demands sophisticated data infrastructure and stringent privacy measures to protect patient information. Furthermore, the cost associated with precision medicine testing remains a significant consideration, requiring a careful balance between personalized healthcare benefits and affordability for patients and the healthcare system alike. Educating both healthcare professionals and patients about the nuances and advantages of non-oncology precision medicine is also crucial for fostering broader acceptance and adoption.
The market is currently witnessing a shift toward greater integration of technology in healthcare, with bioinformatics playing a central role in the development of personalized treatment plans. Additionally, there is a notable trend towards preventive healthcare approaches, emphasizing early detection and intervention to enhance patient outcomes. As genetic testing becomes more ubiquitous, its role in routine healthcare practices is expanding, making precision medicine a cornerstone of contemporary medical strategies in Vietnam.
Significant growth opportunities are emerging within the Vietnam Non-Oncology Precision Medicine market. The increasing prevalence of chronic diseases and the demand for tailored healthcare solutions create avenues for innovative startups and established companies alike. Furthermore, as collaboration between healthcare entities and technology firms grows, new methodologies and applications are likely to be developed, paving the way for expanded service offerings and improved patient outcomes.
The Vietnamese government has been proactive in enhancing the healthcare landscape through various policies and initiatives that support precision medicine. Investments in healthcare infrastructure, public health programs, and research and development are designed to create a favorable environment for precision medicine adoption. These efforts aim to bolster local capabilities, foster innovation, and ensure that healthcare providers are equipped to meet the growing demand for personalized medical solutions.
Looking ahead to 2026-2032, the Vietnam Non-Oncology Precision Medicine market is poised for substantial growth as healthcare providers increasingly recognize the importance of personalized treatment strategies. The continuous evolution of genetic testing technologies, combined with supportive government initiatives and a growing emphasis on preventive healthcare, will drive market expansion. With a focus on addressing the unique health needs of the population, precision medicine is set to play an instrumental role in the future of Vietnam’s healthcare landscape.
Recent developments within the Vietnam Non-Oncology Precision Medicine market reflect a growing commitment to enhancing healthcare solutions. Innovations in genetic testing methodologies and collaborations between academic institutions and biotech companies are becoming more common. Additionally, the emphasis on integrating artificial intelligence into diagnostic processes is gaining traction, promising to further refine personalized treatment protocols. These advancements signal a robust forward momentum in the sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Non-Oncology Precision Medicine Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Vietnam Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2022 & 2032F |
4 Vietnam Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Vietnam leading to the demand for precision medicine |
4.2.2 Growing awareness and adoption of personalized healthcare solutions in the country |
4.2.3 Government initiatives and investments in healthcare infrastructure and technology |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine technologies and treatments |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Vietnam |
4.3.3 Lack of standardized regulations and guidelines for non-oncology precision medicine practices |
5 Vietnam Non-Oncology Precision Medicine Market Trends |
6 Vietnam Non-Oncology Precision Medicine Market, By Types |
6.1 Vietnam Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2022-2032F |
6.1.3 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2022-2032F |
6.1.4 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.1.5 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2022-2032F |
6.1.6 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2022-2032F |
6.1.7 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2022-2032F |
6.2 Vietnam Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2022-2032F |
6.2.3 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2022-2032F |
6.2.4 Vietnam Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2022-2032F |
7 Vietnam Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Vietnam Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Vietnam Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Vietnam Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering non-oncology precision medicine services |
8.2 Percentage increase in RD investments in precision medicine within Vietnam |
8.3 Rate of adoption of personalized treatment plans by healthcare providers |
8.4 Patient satisfaction scores with non-oncology precision medicine treatments offered |
8.5 Number of successful clinical trials and research studies conducted in the field |
9 Vietnam Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Vietnam Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 Vietnam Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2022 & 2032F |
10 Vietnam Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Vietnam Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here